Valuation: Precision Therapeutics Inc

Market Cap 14Cr 12Cr 12Cr 11Cr 20Cr 1.35TCr 20Cr 138.67Cr 54Cr 685.92Cr 53Cr 52Cr 2.21TCr P/E 2024
-0.35x
P/E 2025 -0.53x
Enterprise Value 13Cr 11Cr 11Cr 9.83Cr 18Cr 1.26TCr 18Cr 129.67Cr 50Cr 641.4Cr 49Cr 48Cr 2.06TCr EV / Sales 2024
4.23x
EV / Sales 2025 121x
Free-Float
94.05%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Precision Therapeutics Inc

Manager TitleAgeSince
Chief Executive Officer 57 09/02/2026
Director of Finance/CFO - 16/04/2026
President - 01/04/2026
Director TitleAgeSince
Director/Board Member 66 19/02/2020
Chairman 78 09/02/2026
Director/Board Member 60 09/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 14Cr
+0.11%+2.71%+0.44%+26.85% 4.63TCr
-1.12%+1.78%+42.30%+27.55% 4.39TCr
-3.04%-6.29%+338.56%+515.97% 4.09TCr
-0.74%+1.25%+4.92%+67.98% 3.99TCr
-0.50%+0.67%+10.29%+41.28% 2.95TCr
-0.46%+4.22%+22.81%+139.44% 1.71TCr
-0.97%-10.17% - - 1.55TCr
-0.57%+8.12%+22.19%+38.68% 1.52TCr
-3.14%+31.91%-11.79% - 1.4TCr
Average -1.80%+3.76%+53.72%+122.54% 2.92TCr
Weighted average by Cap. -1.10%+1.87%+68.04%+130.90%

Financials

2024 2025
Net sales 16.24L 14.16L 13.37L 12.14L 22.75L 16Cr 22.84L 1.6Cr 61.8L 7.92Cr 61L 59.64L 25Cr 1L 1L 1L 93.67T 2L 1.2Cr 2L 12.36L 5L 61.12L 5L 5L 1.97Cr
Net income -1.27Cr -1.1Cr -1.04Cr -94.69L -1.77Cr -121.52Cr -1.78Cr -12Cr -4.82Cr -62Cr -4.76Cr -4.65Cr -198.79Cr -23Cr -20Cr -19Cr -17Cr -33Cr -2.24TCr -33Cr -229.9Cr -89Cr -1.14TCr -88Cr -86Cr -3.66TCr
Net Debt 13.96L 12.18L 11.5L 10.44L 19.56L 13Cr 19.64L 1.38Cr 53.14L 6.81Cr 52.45L 51.29L 22Cr -91.25L -79.57L -75.13L -68.22L -1.28Cr -88Cr -1.28Cr -9Cr -3.47Cr -45Cr -3.43Cr -3.35Cr -143.23Cr
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!